ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JULY 2025

Zinzino group revenue increased with a total of 55%, compared with the previous year.

The revenue in July for Zinzino's sales markets increased by 64% and amounted to SEK 259.9 (158.8) million. Faun Pharma's external sales decreased and amounted to SEK 2.2 (10.3) million. Overall, the Group increased revenues by 55% to SEK 262.1 (169.1) million compared with the previous year.

Accumulated revenue for January – July 2025 increased by 57 % to SEK 1,780.1 (1,130.7) million.
 

Revenues were distributed as follows:
 

Regions,MSEK	25-Jul	24-Jul	Change	YTD 2025	YTD 2024	Change
The Nordics	26.1	23.4	12%	181.3	164.9	10%
Central Europe	76.1	44.1	73%	491.1	299.9	64%
East Europe	31.3	29.0	8%	217.8	220.6	-1%
South & West Europe	47.3	33.3	42%	309.3	193.6	60%
The Baltics	10.0	8.0	25%	66.8	55.5	20%
North America	47.2	16.7	183%	299.5	98.1	205%
Asia-Pacific	20.0	2.9	590%	169.0	28.2	499%
Africa	1.9	1.4	36%	12.1	8.3	46%
Zinzino	259.9	158.8	64%	1746.9	1069.1	63%
Faun Pharma	2.2	10.3	-79%	33.2	61.6	-46%
Zinzino Group	262.1	169.1	55%	1780.1	1130.7	57%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium,
Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: DNB Carnegie Investment Bank AB (publ.)